PMID- 37968555
OWN - NLM
STAT- MEDLINE
DCOM- 20240115
LR  - 20240123
IS  - 1573-2568 (Electronic)
IS  - 0163-2116 (Linking)
VI  - 69
IP  - 1
DP  - 2024 Jan
TI  - Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the 
      Indications.
PG  - 7-9
LID - 10.1007/s10620-023-08153-3 [doi]
AB  - The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated 
      with increased risks of long-term mortality, decompensation, hepatic 
      encephalopathy, spontaneous bacterial peritonitis, and infection, but not with 
      short-term mortality. Ensure clear indications at lowest effective dose of is 
      mandatory for the use of PPI among cirrhotic patients.
CI  - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business 
      Media, LLC, part of Springer Nature.
FAU - Low, En Xian Sarah
AU  - Low EXS
AD  - Endoscopy Center for Diagnosis and Treatment, Department of Medicine, Taipei 
      Veterans General Hospital, Taipei, Taiwan.
FAU - Wang, Yen-Po
AU  - Wang YP
AD  - Endoscopy Center for Diagnosis and Treatment, Department of Medicine, Taipei 
      Veterans General Hospital, Taipei, Taiwan.
AD  - Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
FAU - Lu, Ching-Liang
AU  - Lu CL
AD  - Endoscopy Center for Diagnosis and Treatment, Department of Medicine, Taipei 
      Veterans General Hospital, Taipei, Taiwan. cllu@nycu.edu.tw.
AD  - Institute of Brain Science, National Yang Ming Chiao Tung Univeristy, Taipei, 
      Taiwan. cllu@nycu.edu.tw.
AD  - Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 
      cllu@nycu.edu.tw.
LA  - eng
PT  - Editorial
DEP - 20231115
PL  - United States
TA  - Dig Dis Sci
JT  - Digestive diseases and sciences
JID - 7902782
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Humans
MH  - Proton Pump Inhibitors/adverse effects
MH  - Liver Cirrhosis/complications/drug therapy
MH  - *Hepatic Encephalopathy/etiology
MH  - *Peritonitis/microbiology
MH  - *Bacterial Infections/drug therapy/complications
OTO - NOTNLM
OT  - Cirrhosis
OT  - Hepatic decompensation
OT  - Hepatocellular carcinoma
OT  - Proton pump inhibitors
OT  - Spontaneous bacterial peritonitis
EDAT- 2023/11/16 06:45
MHDA- 2024/01/15 12:43
CRDT- 2023/11/16 00:06
PHST- 2023/09/28 00:00 [received]
PHST- 2023/10/09 00:00 [accepted]
PHST- 2024/01/15 12:43 [medline]
PHST- 2023/11/16 06:45 [pubmed]
PHST- 2023/11/16 00:06 [entrez]
AID - 10.1007/s10620-023-08153-3 [pii]
AID - 10.1007/s10620-023-08153-3 [doi]
PST - ppublish
SO  - Dig Dis Sci. 2024 Jan;69(1):7-9. doi: 10.1007/s10620-023-08153-3. Epub 2023 Nov 
      15.